AACE Annual Meeting
Thyroid
Maria E. Cabanillas, MD, FACE
Professor
The University of Texas MD Anderson Cancer Center
Houston , Texas, United States
Disclosure: Bayer (Self) : Consulting Fees (e.g., advisory boards) (Status: Ongoing); Eisai (Self) : Research Grant (Status: Terminated --- 11/15/2019); Eli Lilly (Self) : Consulting Fees (e.g., advisory boards) (Status: Ongoing), Research Grant (Status: Ongoing); Exelixis (Self) : Consulting Fees (e.g., advisory boards) (Status: Ongoing), Research Grant (Status: Ongoing); Genentech (Self) : Research Grant (Status: Ongoing); LOXO (Self) : Consulting Fees (e.g., advisory boards) (Status: Ongoing), Honorarium (Status: Ongoing), Research Grant (Status: Ongoing); Merck (Self) : Research Grant (Status: Ongoing)
Mimi Hu, MD
Professor
The University of Texas MD Anderson Cancer Center
Houston, Texas, United States
Disclosure: Blueprint Medicines (Self) : Consulting Fees (e.g., advisory boards) (Status: Terminated --- 12/01/2020); Eli Lilly (Self) : Consulting Fees (e.g., advisory boards) (Status: Ongoing), Contracted Research (Status: Ongoing); Targeted Oncology (Self) : Honorarium (Status: Terminated --- 12/16/2020), Speaker for Educational Program (Status: Terminated --- 12/16/2020); Veracyte (Self) : Consulting Fees (e.g., advisory boards) (Status: Terminated --- 3/28/2020)